Main

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2025-08-06 13:18:13

expired found date

-

created at

2024-07-22 19:52:43

updated at

2025-09-26 11:43:27

Domain name statistics

length

12

crc

53322

tld

0

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

127202225

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

143590

mp size raw text

7765

mp inner links count

12

mp inner links status

10 (links queued, awaiting import)

Open Graph

title

PROVENGE® (sipuleucel-T)

description

What is metastatic castration-resistant prostate cancer? Metastatic castration-resistant prostate cancer (mCRPC) is a form of advanced prostate cancer.

site name

PROVENGE (sipuleucel-T)

author

updated

2026-03-04 07:02:42

raw text

PROVENGE® (sipuleucel-T) Skip to content PROVENGE (sipuleucel-T) Main Menu Advanced Prostate Cancer Show submenu mCRPC Immunotherapy Your PROVENGE Journey Resources Show submenu Patient Testimonials Coverage & Patient Support About PROVENGE Important Safety Information Full Prescribing Information Download a Brochure Find A Doctor Attend an Event For HCPs Search Advanced Prostate Cancer Show submenu mCRPC Immunotherapy Your PROVENGE Journey Resources Show submenu Patient Testimonials Coverage & Patient Support About PROVENGE Learn more about PROVENGE Immunotherapy For Advanced Prostate Cancer It’s About MORE TIME PROVENGE is a personalized immunotherapy that activates the immune system to help fight advanced prostate cancer and has been proven to help certain men with metastatic castration-resistant prostate cancer (mCRPC) live longer. Learn more about PROVENGE Learn more about PROVENGE What is metastatic cast...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Medicine [en] (226)

index version

2026022801

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

6227

text words

1147

text unique words

428

text lines

117

text sentences

52

text paragraphs

20

text words per sentence

22

text matched phrases

32

text matched dictionaries

2

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap status

10 (sitemap found, awaiting processing)

sitemap review version

2

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

2025-08-15 14:02:48

sitemap process date

-

sitemap first import date

-

sitemap last import date

-